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Abstract:
Background: Doppler echocardiographic studies of the left ventricle (LV) function in patients with β-Thalassemia Major (β-TM) had 
shown different patterns of systolic and diastolic dysfunctions associated with abnormal serum brain natriuretic peptide (BNP).
Aim: This cross-sectional study was designed to study the LV systolic and diastolic functions and correlate that with serum level of N-terminal 
pro brain natriuretic hormone (NT- pro BNP) in patients with β-TM using Pulsed Doppler (PD) and Tissue Doppler (TD) echocardiography.
Methods: The study was conducted on patients with β-TM (n = 38, age 15.7 ± 8.9 years) and compared with an age-matched controls 
(n = 38, age 15.9 ± 8.9 years). In all participants, PD and TD echocardiography were performed and blood samples were withdrawn for 
measuring the serum level of NT-pro BNP, ferritin, and alanine transaminase.
Results: Patients with β-TM compared with controls, have thicker LV septal wall index (0.65 ± 0.26 vs. 0.44 ± 0.21 cm, P , 0.001), 
posterior wall index (0.65 ± 0.23 vs. 0.43 ± 0.21 cm, P , 0.01), and larger LVEDD index (4.35 ± 0.69 vs.3.88 ± 0.153 mm, P , 0.001). 
In addition, β-TM patients have higher transmitral E wave velocity (E) (70.818 ± 10.139 vs. 57.532 ± 10.139, p = 0.027) and E/A 
ratio (1.54 ± 0.17 vs. 1.23 ± 0.19, P , 0.01) and shorter deceleration time (DT) (160.13 ± 13.3 vs. 170.50 ± 19.20 m sec, P , 0.01). 
  Furthermore, the ratio of transmitral E wave velocity to the tissue Doppler E wave at the basal septal mitral annulus (E/Em−) was 
­ significantly­higher­in­β-TM group (19.6 ± 2.81 vs. 13.868 ± 1.41, P , 0.05). The tissue doppler systolic wave (Sm) velocity and 
the­early­diastolic­wave­(Em)­were­significantly­lower­in­β-TM group compared to controls (Sm: 4.82 ± 1.2 vs. 6.22 ± 2.1 mm/sec, 
P , 0.05; Em: 3.51 ± 2.7 vs. 4.12 ± 2.5 mm/sec P ,­0.05,­respectively).­The­tricuspid­valve­velocity­was­significantly­higher­in­β-TM 
patients compared with controls (2.993 ± 0.569 vs. 1.93 ± 0.471 m/sec, respectively, P , 0.01). The mean serum NT pro-BNP in β-TM 
was­significantly­higher­compared­with­controls­(37.6­± 14.73 vs. 5.5 ± 5.4pg/ml, P , 0.05). The left ventricle ejection fraction (EF%) 
and­fractional­shortening­(FS%)­were­not­significantly­different­between­both­groups.
Conclusion: We conclude that patients with β-TM­had­a­significantly­higher­serum­level­of­NT-pro­BNP­that­is­positively­correlated­
with­the­E/Em­ratio­on­tissue­Doppler.­Furthermore,­we­confirm­our­previous­findings­that­patients­with­β-TM exhibit LV diastolic 
  pattern on echocardiogram suggestive of restrictive type with well preserved left ventricle systolic function.
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Introduction
Patients  with  beta-thalassemia  major  (β-TM)  are 
maintained on continuous blood transfusion regimens 
to keep hemoglobin levels close to normal and allow 
adequate tissue oxygenation. Hemolysis of red blood 
cell and repeated blood transfusion in β-TM is asso-
ciated with iron overload.1 Iron deposition adversely 
affect both the structure and function of the heart and 
other  vital  organs.2  Treatment  with  iron  chelating 
therapy in patients with β-TM showed improvement 
of morbidity and increased survival and is considered 
the standard of care of this blood disorder.3
Brain natriuretic peptide (BNP) is a 32-amino acid 
polypeptide secreted primarily by the left   ventricle 
(LV)  in  response  to  increased  stretching  or  wall 
  tension of the heart muscle cells. At the time of BNP 
release,  the  inactive  NT-pro  BNP  is  cleaved  from 
the  precursor  peptide  pro  BNP  and  is    co-secreted 
in   quantities directly proportional to its biologically 
active counterpart (BNP).4 Both BNP and   NT-pro-BNP 
have been shown earlier to be sensitive biomarkers 
for  the  detection  of  asymptomatic  LV  dysfunction 
and that they had important diagnostic and prognostic 
implications in patients with LV dysfunction.5 The 
prognostic predictive value of NT-pro BNP in patients 
with thalassemia major as a model disease with iso-
lated diastolic dysfunction has been assessed where 
there were a direct relationship between the diastolic 
indices on echo Doppler and the serum level of the 
NT-pro BNP.6,7
LV­diastolic­filling­patterns­have­been­classified­into­
normal, restrictive and abnormal relaxation patterns 
on­the­basis­of­early­filling­E­wave­and­late­filling­
A­wave­on­the­pattern­of­LV­diastolic­filling.8 The 
filling­pattern­depends­on­the­degree­of­predominance­
of  the  abnormal  active  relaxation  or  altered  wall 
stiffness. The restrictive pattern is characterized by 
high E wave velocity, decreased A wave, shortened 
deceleration Time (DT) with high E/A ratio.9–12
The  tissue  Doppler  echocardiography  (TD)  can 
detect  regional  myocardial  diastolic  dysfunction 
even in early phases of cardiac injury.13 The tissue 
  velocity at the basal septum of mitral annulus has 
been evaluated as a marker of myocardial stiffness, 
and in one report it was suggested that the ratio of 
early­ ­ diastolic­ ­ filling­ wave­ (E)­ to­ mitral­ annulus­
velocity (Em) does correlates positively with the LV 
  end-diastolic  pressure  (LVEDP).14  Furthermore,  it 
was shown that TD velocities of the early diastolic 
wave (Em) and systolic wave (Sm) were both reduced 
in stiff hypertensive myocardium.15
The aim of this study is to examine the relationship 
between  the  serum  level  of  NT-pro  BNP  and  LV 
  diastolic function using different echocardiographic 
indices of tissue Doppler echocardiogram in patients 
with β-TM in the absence of overt heart failure.
Material and Methods
This  study  included  38  patients  with  transfusion-
dependent  β-TM  and  32  healthy  individuals  who 
were used as a control group. A constitutional ethical 
approval was obtained for the study.
The study was conducted over six month period 
from September 2009 to March 2010.
Patients’ selection was consecutive from those who 
are on regular follow-up in the Pediatric   Hematology 
clinic  at  Salmaniya  Medical  Complex  (SMC)  in 
Bahrain.
Inclusion and exclusion criteria
Patients  were  included  if  they  had  a  follow-up  for 
more­than­3­years­at­SMC,­with­a­confirmed­diagnosis­
of β-TM based on electrophoresis. Each patient had 
been receiving blood transfusions every three weeks to 
maintain hemoglobin levels above 9 g/dl since infancy. 
All patients had also been receiving oral deferasirox 
as a chelating therapy (20 mg/kg/day) regularly for 
at least six months. In the control group, individuals 
were healthy with no renal or hepatic   diseases, no car-
diac valve diseases, normal LV function on echo and 
negative blood tests for thalassemia. The control group 
was selected from the pool of age-matched healthy 
individuals who were referred for evaluation of a sys-
tolic murmur and turned out to have normal echo.
The blood sampling in the β-TM group and the 
echo test were carried out at the end of the week prior 
to the blood transfusion. Patients were excluded if 
they have an end-stage renal disease with   creatinine 
clearance ,30% of normal, severe liver disease, dia-
betes mellitus, hypoparathyroidism, advanced heart 
failure, hypertrophic cardiomyopathy or if the patient 
is taking active cardiac medications.
Clinical and biochemical variables
Each patient in the study had a clinical and hema-
tological­ data­ file­ including­ duration­ of­ ­ disease,­pro-BnP serum level and echocardiographic tissue doppler abnormalities
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  cardiovascular  assessment  for  pulse  rate,  jugular 
venous  pressure  wave,  apex  beat,  blood  pressure, 
heart  sounds  and  any  murmurs,  ankle  edema  and 
body weight. Data of the blood level of hemoglobin, 
serum level of NT-pro BNP, serum ferritin, alanine 
transferase and creatinine were all recorded.
Doppler echocardiography
Each patient in the study had the echo examination by 
2.5–5 MHz transducer, using HP E33 echo machine. 
The echocardiography tests were   performed by an 
echo technologist who was blinded about the   clinical 
condition of the patient. Data were reported as an 
average­of­at­least­five­cardiac­cycles.­Another­echo­
technician analyzed the data blindly, and the data were 
taken as an average of two readings. All measurements 
were conducted according to the   recommendations of 
the American Society of Echocardiography (ASE).16
Each patient enrolled in the study had echocardio-
graphic measurements including M-mode, 2D echo, 
color­flow,­LV­systolic­and­diastolic­transmitral­indices­
and  tissue  Doppler  evaluation  of  the    septal  mitral 
annulus. The M-mode echo parameters including the 
LV septal wall thickness, posterior LV wall thickness, 
mid and basal LV   cavity dimension in systole and 
  diastole  as  well  as  the  LV  end-diastolic  volume 
(EDV). LV fractional shortening (FS%) and LV ejec-
tion  fraction  percentage  (LVEF%)  were    measured 
using Teichholz formula: V = {7.0/(2.4 + D) * D3}.17 
Pulsed   Doppler was acquired in the apical view, while 
patients in the partial left   lateral decubitus   position 
during  the  end  of  expiration,  with  sample  volume 
situated­between­the­mitral­­ leaflet­tips.
The­ LV­ diastolic­ filling­ indices­ including­ early­
diastolic wave (E wave), late diastolic wave (A wave), 
E wave to A wave (E/A) ratio, deceleration time of 
E wave (DT) and isovolumic relaxation time (IVRT) 
were all measured with the sample volume at the tip 
of­the­mitral­leaflets­in­the­apical­view.­The­tricus-
pid valve velocity in systole (cm/s) was measured in 
apical view. The tissue Doppler velocity of the septal 
mitral­annulus,­early­filling­E­wave­velocity­(Em),­
the calculated E/Em ratio and the systolic wave (Sm) 
were­all­were­recorded­as­a­mean­of­five­readings.
Statistical analysis
All data were entered and analyzed using the Statistical 
Package  of  Social  Sciences  (SPSS)  version  17.0. 
Data are presented as mean ± SD. Unpaired student 
t-test was used to analyze the differences between 
the variables in the control and the β-TM groups. 
The M-mode dimensions of the LV were adjusted 
and indexed for Body Surface Area (BSA) of each 
patient. Linear regression analysis was used to assess 
the correlation between the serum NT- pro BNP and 
E/Em­ratio.­The­correlation­coefficient­(r)­of­the­slope­
was then calculated. The mean of tissue Doppler indi-
ces taken at septal mitral annulus ring of the LV were 
corrected for heart rate.
All other pulsed and tissue Doppler indices for 
systolic  and  diastolic  functions  were  corrected  for 
heart rate such as: E wave velocity, A wave velocity, 
DT,  IVRT,  Em,  E/Em,  Sm.  Differences  between 
groups­were­considered­statistically­significant­at­a­
probability value of ,0.05.
Results
The  demographic  data  of  β-TM  patients  and  the 
healthy controls are summarized in Table  1. The 
β-TM­ patients­ had­ a­ significantly­ lower­ body­
surface  area  compared  with  control  patients 
(1.02 ± 0.2 vs. 1.15 ± 0.2, P , 0.05). There was 
no­significant­difference­in­the­mean­age­between­
the β-TM group (15.92 ± 8.92 year, range; 7–25) 
and the control group (15.79 ± 8.94 years, range; 
6–24) with comparable gender distribution between 
the two groups.
Table 2 shows the hemodynamic and biochemical 
variables in both groups. The systolic and diastolic 
pressure  values  were  comparable  in  both  groups. 
The heart rate was lower in the β-TM compared with 
control group (68.16 ± 7.40 vs.72.92 ± 6.08 bpm 
respectively,  P  ,  0.05).  The  mean  serum  NT 
Table 1. Demographic characteristics of control (n = 32) 
and thalassemia patients (n = 38) in the study. 
control group 
(n = 32)
β-TM group 
(n = 38)
P value
Age (Years) 15.79 ± 8.94 15.92 ± 8.92 0.92
Male 22 (57%) 23 (60%) 0.75
Weight (kg) 41.26 ± 8.60 31.00 ± 7.87 0.034
height (cm) 135.66 ± 8.80 134.87 ± 9.74 0.001
BSA 1.15 ± 0.20 1.02 ± 0.20 0.001
notes: Data are presented as mean ± SD. P value , 0.05 is considered 
statistically significant.
Abbreviation: BSA, body surface area.garadah et al
138  Clinical Medicine Insights: Cardiology 2010:4
  pro-BNP  in  β-TM­ was­ significantly­ higher­
  compared with controls (37.62 ± 14.73 pg/ml ver-
sus  5.53  ±  5.41pg/ml  respectively,  P  ,  0.001). 
The­serum­ferritin­level­was­significantly­higher­in­
the β-TM group compared with the control group 
(5124 ± 1931 pg/ml vs. 164 ± 48 pg/ml, P , 0.001). 
There­were­no­significant­differences­in­serum­levels­
of creatinine, alanine transaminase and hemoglobin 
between the two groups.
Echocardiographic findings
Table  3  summarizes  the  indexed  pulsed  M-mode 
values in both control and β-TM groups. The β-TM 
group­showed­significantly­higher­LV­wall­thickness­
manifested­by­significantly­thicker­posterior­wall­and­
inter-ventricular  septum  (P  ,  0.001  in  both). The 
LV dimensions at the end of systole (LVESD) and 
diastole­(LVEDD)­were­significantly­larger­in­β-TM 
compared with control group. The left ventricle mass 
Table 2. hemodynamic and biochemical parameters in beta thalassemia (β-TM) patients on deferasirox (20 mg/kg/day) 
and the control group.
parameter control group 
(n = 32)
β-TM group 
(n = 38)
P value
Systolic pressure (mmhg) 128.16 ± 12.49 123.34 ± 13.27 0.108
Diastolic pressure (mmhg) 74.71 ± 7.61   71.26 ± 7.21 0.102
heart rate (bpm) 72.92 ± 6.08   68.16 ± 7.40 0.04
Serum pro-BnP (pg/ml) 5.53 ± 5.41   37.62 ± 14.73 0.001
Serum ferritin (μg/L)    164 ± 48    5124 ± 1931 0.001
Serum creatinine (μmol/l) 80.80 ± 10.12   75.23 ± 11.13 0.076
Serum alanine transaminase (U/L)     39 ± 10.72   40.45 ± 14.83 0.085
hemoglobin (gm/dl) 10.23 ± 0.51     9.5 ± 0.42 0.065
notes: Data are presented as mean ± SD. P , 0.05 is considered statistically significant.
Table 3. Indexed M-Mode and 2D echocardiography findings in beta thalassemia (β-TM) patients and the control group. 
parameter control group 
(n = 32)
β-TM group 
(n = 38)
P value
IVS (cm/m2)   0.44 ± 0.22 0.65 ± 0.26 ,0.001
PW (cm/m2)   0.43 ± 0.21 0.65 ± 0.24 ,0.001
LVeDD (mm/m2)   3.89 ± 0.15 4.35 ± 0.70 ,0.001
LVeSD (mm/m2)   2.72 ± 0.17 2.85 ± 0.47 ,0.01
LV mass (gm/m2) 87.65 ± 14.76 172.85 ± 65.30 ,0.001
LVeF (%) 59.00 ± 3.33 63.47 ± 6.76 0.089
FS (%) 32.37 ± 4.36 34.41 ± 3.36 0.107
notes: Data are presented as mean ± SM per body surface area (m2). P , 0.05 is considered statistically significant. 
Abbreviations: IVS, inter ventricular septal thickness; PW, posterior wall thickness; LVeDD, left ventricle end diastolic diameter; LVeSD, left ventricle end 
systolic diameter; FS, fractional shortening; LVeF, left ventricular ejection fraction.
was­ significantly­ higher­ in­ β-TM  group  compared 
with the control (172.85 ± 65.30 vs. 87.65 ± 14.76 
respectively, P , 0.001).
Compared  with  the  control  group,  patients 
with  β-TM  had  slightly  higher  LVEF%  and  FS, 
but these differences did not achieve the statistical 
significance.
Table 4 shows the pulsed and tissue Doppler indices 
of the LV in both groups. The pulsed Doppler veloci-
ties­of­LV­in­diastolic­showed­significantly­higher­
E wave, and E/A ratio in β-TM group compared to 
control­while­significantly­shorter­interval­of­DT­time­
and higher velocity of E wave. The ratio of transmi-
tral E wave velocity to TD (Em) of the septal mitral 
annulus­(E/Em)­was­significantly­higher­in­the­β-TM 
group  compared  to  the  control  group  (P  ,  0.05), 
while the early diastolic velocity (Em) and the sys-
tolic­wave­velocity­(Sm)­were­significantly­lower­in­
β-TM group (P , 0.05).pro-BnP serum level and echocardiographic tissue doppler abnormalities
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The  LV  fractional  shortening  and  LVEF%  at 
mid-cavity­sector­were­with­not­significantly­different­
between the two groups.
There­ was­ a­ significant­ positive­ correlation­
between the pro BNP and the E/Em ratio (r = 0.31, 
P , 0.001).
The­ tricuspid­ valve­ velocity­ was­ significantly­
higher in β-TM group (P , 0.01). In patients with 
β-TM­ group,­ the­ color­ flow­ and­ continuous­ wave­
velocity of the LV and RV showed mild mitral regur-
gitation in nine patients and three patients had mild 
aortic regurgitation with none in the control group.
Discussion
In  this  study,  patients  with  β-TM  were  evaluated 
with  pulse  and  tissue  Doppler  echocardiogram  for 
  systolic and diastolic functions of the left ventricle 
(LV) compared with age and sex-matched individuals 
with no β-TM (controls). Compared with controls, 
the   diastolic indices of LV in β-TM patients showed 
higher­ early­ diastolic­ filling­ of­ LV­ and­ E/A­ ratio­
  suggesting restrictive diastolic pattern and stiff myo-
cardial­wall.­These­findings­are­in­keeping­with­one­
study by Yaprak et al.18 who demonstrated that β-TM 
patients­had­significantly­higher­E­wave,­E/A­ratio,­
and lower A wave velocity, suggesting a restrictive 
pattern but with no correlation with hemoglobin level. 
Similar observations were reported by Spirit et al.19 
who  demonstrated  a  restrictive  pattern  in  patients 
with β-TM with no heart failure. This was also in 
agreement with a previous report that high E/A ratio 
is­the­most­common­finding­in­patients­with­β-TM.20
In one study, the magnitude of E wave velocity is 
governed by the initial left ventricular   pressure and 
shown to be directly related to it,21 the decreased DT of 
E wave was mostly related to the increased amplitude 
of  the  E  wave  and  may  be  due  to  the  impaired 
relaxation  of  LV  with  a  constrictive  pattern.  The 
exact­mechanism­of­these­findings­is­not­known­but­
may be due to iron overload and increased stiffness 
of LV wall.
The­tissue­Doppler­ratio­of­E/Em­was­significantly­
higher  in  β-TM  patients  compared  with  controls. 
Likewise, the early diastolic velocity (Em) and the 
systolic velocity wave (Sm) of the basal   septum were 
significantly­ reduced,­ suggesting­ stiff­ ­ myocardium­
and­ possibly­ high­ LVEDP.­ These­ findings­ are­
in    agreement  with  those  previously  reported  in 
  hypertensive patients.22,23
The LVEF% and fractional shortening in mid   cavity 
sector were normal indicating that β-TM patients are 
having a preserved systolic function. In the current 
study,  the  serum  ferritin  was  more  than  30  times 
higher in the β-TM group compared with controls. 
These­ findings­ confirm­ our­ previously­ ­ published­
  studies  that  iron  overload  appear  to    mediate  the 
impaired diastolic function leading to stiffness of the 
myocardial wall but with well preserved LV systolic 
function.24  However,  increased  serum  ferritin  con-
centration may not be associated with a concordant 
Table 4. The heart rate corrected diastolic Doppler indices for β-thalassemia (β-TM) patients. 
parameter control group 
(n = 32)
β-TM group 
(n = 38)
P value
Mitral inflow velocities
e (cm/sec) 57.53 ± 10.14 70.82 ± 10.1 0.027
A (cm/sec) 46.34 ± 10.76 45.53 ± 9.82 0.109
e/A ratio 1.23 ± 0.17 1.54 ± 0.18 0.001
DT (msec) 170.50 ± 19.20 160.53 ± 13.30 0.047
IVrT (msec) 79.50 ± 5.72 75.21 ± 6.37 0.083
Doppler tissue imaging
em (cm/s) 4.12 ± 2.50 3.51 ± 2.70 0.04
Sm (cm/s) 6.22 ± 2.10 4.82 ± 1.20 0.02
e/em ratio 13.86 ± 1.41 19.68 ± 2.81 ,0.05
Tricuspid velocity (cm/sec) 1.74 ± 0.47 2.85 ± 0.57 0.045
notes: Data are presented as mean ± SD. P , 0.05 is considered statistically significant.
Abbreviations: IVRT, isovolumic relaxation time; E, early diastolic flow velocity; A, late diastolic flow velocity; DT, deceleration time of flow velocity in early 
diastole; Sm, systolic myocardial velocities of basal segments of LV lateral wall; em, early diastolic myocardial velocities of the same basal segments.garadah et al
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and comparable increase in myocardial iron content. 
Future studies which examine the cardiac iron con-
tent by using more sensitive measures such as MRI 
will be required.
In this study, the serum level of pro-BNP in patients 
with β-TM in the absence of overt heart failure was 
not exceeding the normal level in our laboratory of 
125­pg/ml,­but­was­significantly­higher­than­the­con-
trol group with a positive correlation with E/Em ratio 
indicating a stiff myocardium with restrictive diastolic 
abnormality. It seems in this population, as observed 
previously, that myocardial disease go through a stage 
of impaired relaxation before development of systolic 
dysfunction.8,9­This­finding­is­in­agreement­with­one­
report where patients with β-TM with no heart failure 
had higher NT-pro-BNP and E/Em ratio compared 
with controls with positive correlation between both 
variables.25 In one study on β-TM patients, it was 
found­that­NT­pro-BNP­serum­level­was­significantly­
increased in patients with documented left ventricular 
diastolic dysfunction on echocardiogram.26
In the β-TM group, the increase ratio of E/Em ratio 
compared with the control group is highly suggestive 
of stiff myocardial wall and increased left ventricular 
end diastolic pressure LVEDP.27
conclusion
We conclude that patients with β-TM­had­a­significantly­
higher serum level of NT-pro BNP that is positively 
correlated  with  the  E/Em  ratio  on    tissue  Doppler. 
Furthermore,­we­confirm­our­previous­findings­that­
patients with β-TM exhibit on echocardiogram a LV 
diastolic pattern suggestive of restrictive type with 
well preserved left ventricle systolic function.
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